Posts by Raymond March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.
Putting Right-to-Try Drug Prices in Perspective


FDA regulation holds part of the blame for high drug prices.

EpiPen Pricing Controversy Reveals Ignorance about Market Competition


Increased competition is the remedy to skyrocketing drug prices.

Dear Congress, Please Don’t Keep Up with the Kardashians!


Kourtney Kardashian spoke on Capitol Hill in an attempt to motivate the federal government to play a larger role in regulating cosmetics. 

FDA Moves Closer to Approving Ecstasy


The FDA has granted MDMA breakthrough therapy status to expedite the approval process by making it easier for drugmakers to begin clinical trials.

Right-to-Try Law Signed!


On May 30, President Trump signed a bill into law allowing terminally ill patients access to potentially lifesaving drugs before they are approved by the Food and Drug Administration.

Curing Diseases Is Sustainable, Government in Healthcare Is Not


While Americans have every reason to be concerned about their healthcare, the belief that private medical companies will not develop and produce products that cure various conditions is unwarranted.

FDA Issues First Mandatory Recall for Contaminated Food


The U.S. Food and Drug Administration recently issued a mandatory recall for Triangle Pharmanaturals, a Las Vegas-based herbal supplements company.

FDA Restricts Sale of Contraceptive Device


The FDA released an order indicating its intent to restrict the sale of the contraceptive device Essure, the only FDA-approved nonsurgical permanent birth control method.

FDA Cracks Down on Online Eye-Exam Company


This past October, the Food and Drug Administration issued a warning letter to Opternative, a company specializing in providing online eye-exams.

The FDA Plans to Regulate Nicotine in Cigarettes


How likely are smokers to quit or cut back once nicotine levels decrease?

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org